Cryopyrin-associated periodic syndrome.
The Israel Medical Association Journal : IMAJ
|December 3, 2014
Summary
Chronic Autoinflammatory Syndrome (CAPS) is a rare NLRP3-linked disease causing systemic inflammation. IL-1 antagonism effectively treats CAPS, improving symptoms and preventing complications like amyloidosis.
Area of Science:
- Genetics and Immunology
- Rare Autoinflammatory Diseases
Background:
- Chronic Autoinflammatory Syndrome (CAPS) is a rare autoinflammatory disease linked to NLRP3 gene mutations.
- These mutations lead to inflammasome overactivation, increased IL-1beta and IL-18 secretion, and systemic inflammation.
- Previously distinct syndromes (FCAS, MWS, NOMID) are now classified under CAPS.
Purpose of the Study:
- To summarize the understanding of CAPS, including its genetic basis, clinical manifestations, diagnostic challenges, and treatment strategies.
- To highlight the importance of genetic testing in diagnosing CAPS.
- To discuss diagnostic delays and misdiagnosis issues, particularly in regions with prevalent autoinflammatory disorders.
Main Methods:
- Review of literature on NLRP3-associated autoinflammatory diseases.
- Analysis of clinical features, genetic mutations, and treatment outcomes.
- Discussion of diagnostic criteria and challenges.
Main Results:
- CAPS presents with a spectrum of symptoms including rash, fever, neurological, musculoskeletal, and ocular issues, progressing to deafness.
- Disease severity and complications (e.g., amyloidosis, developmental delay) correlate with specific NLRP3 mutations.
- Diagnosis is confirmed by genetic testing but often delayed due to low awareness and potential misdiagnosis.
Conclusions:
- CAPS is a unified syndrome under the NLRP3 gene, with variable clinical presentations.
- Early diagnosis via genetic testing is crucial to prevent severe complications.
- IL-1 antagonism is an effective treatment, leading to rapid clinical improvement and preventing long-term damage such as amyloidosis.
Related Concept Videos
01:32Postsynaptic Potential (PSP)
11.7K
Postsynaptic potential (PSP) refers to a change in the electrical potential of a neuron when neurotransmitters released by presynaptic neurons bind to postsynaptic receptors. This potential can either be excitatory, leading to depolarization and ultimately action potential generation, or inhibitory, leading to hyperpolarization and suppression of the postsynaptic neuron.
There are two types of receptors: ionotropic and metabotropic.
The ionotropic receptor is the membrane protein that has an...
There are two types of receptors: ionotropic and metabotropic.
The ionotropic receptor is the membrane protein that has an...
11.7K
01:23Cystic Fibrosis: Pathogenesis
1.1K
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
01:25Chronic Pancreatitis I: Introduction
17
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80%...
17